U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
1692116921Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical HyperplasiaRecruitingNo Results AvailableComplex Endometrial Hyperplasia With Atypia|Stage IA Uterine Corpus Cancer|Stage IB Uterine Corpus Cancer|Stage II Uterine Corpus CancerBehavioral: Weight Loss Specialist|Other: Quality-of-Life Assessment|Other: Medical Chart Reviewhttps://ClinicalTrials.gov/show/NCT02342730
1692216922Relative Bioavailability of a Single Oral Dose of BI 425809 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male SubjectsCompletedNo Results AvailableHealthyDrug: BI 425809|Drug: Itraconazole|Drug: BI 425809https://ClinicalTrials.gov/show/NCT02342717
1692316923Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) ParticipantsRecruitingNo Results AvailableRelapsing-Remitting Multiple SclerosisDrug: natalizumab|Drug: fingolimodhttps://ClinicalTrials.gov/show/NCT02342704
1692416924Safety and Preliminary Efficacy of Lipoxin Analog BLXA4-ME Oral Rinse for the Treatment of GingivitisRecruitingNo Results AvailableGingival InflammationDrug: BLXA4|Drug: Placebo oral rinsehttps://ClinicalTrials.gov/show/NCT02342691
1692516925Lessening Incontinence Through Low-impact ActivityRecruitingNo Results AvailableUrinary IncontinenceBehavioral: Yoga Therapy|Behavioral: Physical Conditioninghttps://ClinicalTrials.gov/show/NCT02342678
1692616926Japanese Phase Ib Copanlisib in Relapsed, Indolent B-cell NHLRecruitingNo Results AvailableLymphoma Non-HodgkinDrug: Copanlisib (BAY80-6946)https://ClinicalTrials.gov/show/NCT02342665
1692716927A Phase 1, 2-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASLAN003 in Healthy Elderly SubjectsCompletedNo Results AvailableHealthy Elderly Subjects (Age ≥55 Years)Drug: ASLAN003|Drug: Matched Placebohttps://ClinicalTrials.gov/show/NCT02342652
1692816928Rifaximin Therapy in Chronic Kidney DiseaseRecruitingNo Results AvailableChronic Kidney DiseaseDrug: Rifaximin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02342639
1692916929Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low Grade Prostate CancerRecruitingNo Results AvailableAdenocarcinoma of ProstateBehavioral: Dashboardhttps://ClinicalTrials.gov/show/NCT02342626
1693016930Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell TransplantationRecruitingNo Results AvailableHematologic Malignancies|Graft-Versus-Host DiseaseBiological: Activated PTCy-MILshttps://ClinicalTrials.gov/show/NCT02342613
1693116931Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)Not yet recruitingNo Results AvailableGastrointestinal Stromal TumorsDrug: Pazopanib|Drug: Trametinibhttps://ClinicalTrials.gov/show/NCT02342600
1693216932Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced CancerRecruitingNo Results AvailableHER2-positive Refractory Advanced CancerDrug: Lapatinibhttps://ClinicalTrials.gov/show/NCT02342587
1693316933F901318 Multiple Ascending Dose StudyRecruitingNo Results AvailableInvasive AspergillosisDrug: F901318https://ClinicalTrials.gov/show/NCT02342574
1693416934The Use of Iodine Impregnated Self-adhesive Plastic Drapes in Prevention of Bacterial Re-colonization in Simulated Knee Surgery. An Experimental RCT.CompletedNo Results AvailableTotal Knee Replacement SurgeryDevice: Ioban 2 incision drape, 3Mhttps://ClinicalTrials.gov/show/NCT02342561
1693516935Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021RecruitingNo Results AvailableHuntington's DiseaseDrug: 20 mg BID of PF-02545920https://ClinicalTrials.gov/show/NCT02342548
1693616936Community-Clinic Partnership to Promote Physical Activity in South Asian WomenEnrolling by invitationNo Results AvailableDiabetes Mellitus|Physical ActivityBehavioral: Physical Activityhttps://ClinicalTrials.gov/show/NCT02342535
1693716937Effect of Remote Ischaemic Conditioning on Clinical Outcomes in STEMI Patients Undergoing PPCINot yet recruitingNo Results AvailableSTEMI|Myocardial Reperfusion InjuryDevice: Remote ischemic conditioning|Device: Sham controlhttps://ClinicalTrials.gov/show/NCT02342522
1693816938Automated Control of End-tidal Volatile Anesthetic ConcentrationCompletedNo Results AvailableDelayed Recovery From AnesthesiaDrug: Desflurane|Drug: Sevoflurane|Drug: Isofluranehttps://ClinicalTrials.gov/show/NCT02342509
1693916939Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the ElderlyNot yet recruitingNo Results AvailableLow-grade Inflammation|Increased Intestinal PermeabilityDietary Supplement: Placebo|Dietary Supplement: Active, only probiotics|Dietary Supplement: Active, blend of berries and probioticshttps://ClinicalTrials.gov/show/NCT02342496
1694016940MSM Product on Attenuating Nasal Provocation With a Standardized Allergenic ChallengeCompletedNo Results AvailableNasal BreathingDietary Supplement: MSMhttps://ClinicalTrials.gov/show/NCT02342483
1694116941Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin UsersRecruitingNo Results AvailablePeptic UlcerDrug: Placebo|Drug: PMK-S005 1|Drug: PMK-S005 2|Drug: PMK-S005 3https://ClinicalTrials.gov/show/NCT02342470
1694216942Electrophysiological Activity of the Anorectum in Children Suspected of Hirschsprung DiseaseNot yet recruitingNo Results AvailableHirschsprungs DiseaseDevice: Child suspected of Hirschsprung diseasehttps://ClinicalTrials.gov/show/NCT02342457
1694316943Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)RecruitingNo Results AvailableTrauma|Surgery|Deep Vein Thrombosis (DVT)|Thromboembolic EventsDrug: Enoxaparin Sodium Injection 30 mg BID|Drug: Enoxaparin Sodium Injection 40 mg QDhttps://ClinicalTrials.gov/show/NCT02342444
1694416944Comparison of a Patient Warming System Using a Forced-air, Non-compressible Under-body Mattress Versus a Regular Forced-air Underbody Mattress System During Pediatric Cardiac CatheterizationWithdrawnNo Results AvailableHypothermiaDevice: Forced air warming compressible|Device: Forced air non-compressiblehttps://ClinicalTrials.gov/show/NCT02342431
1694516945Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese AdultsNot yet recruitingNo Results AvailableObesityDrug: Tedizolid phosphatehttps://ClinicalTrials.gov/show/NCT02342418
1694616946High Inspiratory Oxygen Fraction on Endothelial Function in Healthy VolunteersCompletedNo Results AvailableEndothelial DysfunctionOther: 80% oxygen|Other: 30% oxygenhttps://ClinicalTrials.gov/show/NCT02342405
1694716947Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot StudyCompletedNo Results AvailablePterygiumDrug: ranibizumabhttps://ClinicalTrials.gov/show/NCT02342392
1694816948TH-302 in Combination With Bevacizumab for GlioblastomaRecruitingNo Results AvailableGlioblastomaDrug: Bevacizumab|Drug: TH-302https://ClinicalTrials.gov/show/NCT02342379
1694916949Characterization of the Prosocial and Prosexual Effects of GHBCompletedNo Results AvailableDepressive Disorder, Major|Bipolar Disorder|Autistic DisorderDrug: GHB 35 mg/kg p.o.|Drug: GHB 20 mg/kg p.o.https://ClinicalTrials.gov/show/NCT02342366
1695016950Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)Not yet recruitingNo Results AvailableNon-Small Cell Lung Cancer|Nonsmall Cell Lung Cancer|Carcinoma, Non-Small-Cell LungDrug: Pacritinib|Drug: Erlotinibhttps://ClinicalTrials.gov/show/NCT02342353

* Görseller ve İçerik tekif hakkına sahip olabilir